Compounds > etoposide
Page last updated: 2024-08-23

etoposide and nsc 366140

etoposide has been researched along with nsc 366140 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adjei, AA; Ames, MM; Charron, M; Kaufmann, SH; Miller, J; Reid, JM; Rowinsky, EK; Sebolt-Leopold, J; Svingen, PA1
Bally, M; Hu, Y; Krishan, A; Mayer, LD; Nie, W; Sridhar, KS1

Other Studies

2 other study(ies) available for etoposide and nsc 366140

ArticleYear
Effect of pyrazoloacridine (NSC 366140) on DNA topoisomerases I and II.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1998, Volume: 4, Issue:3

    Topics: Acridines; Antineoplastic Agents; Cell Survival; Doxorubicin; Etoposide; Humans; Leukemia, Myeloid; Pyrazoles; Saccharomyces cerevisiae; Subcellular Fractions; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Cells, Cultured

1998
Synergistic cytotoxicity of pyrazoloacridine with doxorubicin, etoposide, and topotecan in drug-resistant tumor cells.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Feb-01, Volume: 10, Issue:3

    Topics: Acridines; Agar; Antigens, Neoplasm; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Catalysis; Cell Line, Tumor; Cell Nucleus; Clinical Trials as Topic; DNA; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Superhelical; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Etoposide; Humans; Inhibitory Concentration 50; Pyrazoles; Topotecan

2004